PipelinePharma Logo
PipelinePharma Logo

CTD Dossier Marketplace

Direct connection with CTD dossier (IP) owners and manufacturers

Marketing Authorizations Database

Search across marketing authorization registers
Sign in Get started

Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-216 manufacturers

Filters

1 products found

pp-216

Gel

Dossier type
CTD
Dossier status
Under development
Country of origin
South Korea
GMP approvals
PICS
Comments
Indication: Moderate-to-severe atopic dermatitis (topical treatment) Clinical stage: Phase 2b — Part 2 enrollment complete February 2026 Modality: Small molecule (taurodeoxycholic acid; GPCR19 agonist / NLRP3 inflammasome inhibitor — NCE) Mechanism / Target: GPCR19 (TGR5 bile acid receptor) agonist and NLRP3 inflammasome inhibitor; dual anti-inflammatory mechanism; reduces IL-1β, IL-18, and type 2 inflammatory cytokines; addresses both pruritus (itch) and skin barrier dysfunction; topical NuGel formulation optimised for skin penetration and drug concentration Route / form: Topical gel (applied to affected skin areas; twice daily) Differentiation: First GPCR19/NLRP3 dual-mechanism topical therapy for atopic dermatitis;
Manufacturer #39352
Publicly listed South Korean clinical-stage biotech developing Rx small molecule NLRP3 inflammasome inhibitors for immunological and inflammatory diseases. Lead program advances novel inflammasome-targeting approaches through clinical trials. Focused on delivering next-generation immunology therapeutics for chronic and acute inflammatory conditions.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.